داروسازی تولید دارو(سهامی خاص)
دتولید | Stocks - Iran Fara Bourse (IFB)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 11,890 2.94
Close Price: 11,880
Income Statement
AGM
Interim
2026/06/13 Fiscal Year 2025/12/2112 Month | 2025/04/19 Fiscal Year 2024/12/2012 Month | 2024/05/25 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Revenue from Services & Sales | 5.509 Trillion | 3.722 Trillion | 6.921 Trillion | |
Total Revenues | 5.509 Trillion | 3.722 Trillion | 6.921 Trillion | |
Cost of Goods Sold | 4.894 Trillion | 3.2 Trillion | 4.961 Trillion | |
Gross Profit | 615.339 Billion | 521.921 Billion | 1.96 Trillion | |
General & Administrative Expenses | 1.162 Trillion | 449.055 Billion | 463.834 Billion | |
Net Operating Income & Expenses | -810.294 Billion | -280.046 Billion | -80.85 Billion | |
Operating Profit (Loss) | -1.356 Trillion | -207.18 Billion | 1.415 Trillion | |
Profit Before Tax | 361.983 Billion | 38.087 Billion | 887.633 Billion | |
Tax | 333.271 Billion | 13.638 Billion | 152.833 Billion | |
Net Profit (Loss) After Tax | 28.712 Billion | 24.449 Billion | 734.8 Billion | |
Retained Earnings at Beginning of Period | 308.719 Billion | 802.182 Billion | 356.356 Billion | |
Approved Dividends — Prior Year AGM | -24 Billion | -516 Billion | -255 Billion | |
Transfer from Other Equity Items | -56.067 Billion | -690 Million | 2.766 Billion | |
Allocable Profit | 257.364 Billion | 309.941 Billion | 838.922 Billion | |
Legal Reserve | 1.436 Billion | 1.222 Billion | 36.74 Billion | |
Approved Dividends — Current Year | 27 Billion | 24 Billion | 516 Billion | |
Retained Earnings at End of Period | 228.928 Billion | 284.719 Billion | 286.182 Billion |